MAULDIN, SC / ACCESSWIRE / September 14, 2023 / Xcelerate, Inc. (OTCQB:"XCRT") today announced that ESN Group, Inc., a subsidiary…
Click here to access webcast replayTop line results expected late October 2023 for company's phase 3 OnTarget trial of crofelemer…
ANN ARBOR, MI / ACCESSWIRE / September 14, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary…
IRVINE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement…
The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to Highly Complex Assays Cytek Reveal…
The risk-based, 2-year (r2) certification validates that the digital health management company meets security, privacy, and compliance requirements for protecting…
Investor Interest in Care Delivery and Expanded Access Marks End of “Psychedelic Winter”LONDON, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Beckley…
Less than 3% of study participants receiving medication for opioid use disorder via telehealth falsified urine drug screening results; just…
Scilex Holding Company announced completion of its SP-103 Phase 2 study to evaluate the safety and efficacy in subjects with…
HAMILTON, BERMUDA , Sept. 14, 2023 (GLOBE NEWSWIRE) -- Fresh data from randomized controlled NASAR clinical trial further demonstrate efficacy…